CENPF and prostate carcinoma: The stem cell marker, ASPM, promotes cell proliferation in prostate cancer 30 through the Wnt signaling pathway 28, and CENPF is involved in the formation of the centromere-kinetochore complex and was correlated with poor prognosis in the PDAC cohort of TCGA (Figure S4A).